Effect of combined aspirin and statin therapy on mortality reduction in sepsis-induced myocardial injury
Open Access
- 9 June 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1839835
Abstract
Introduction: Sepsis-induced myocardial injury (SIMI) is a severe complication with high mortality and limited effective treatments. Although combined aspirin and statin therapy is cardioprotective in coronary artery disease, its impact on SIMI outcomes remains unclear. Methods: Using the MIMIC-IV database, we evaluated the association of combined aspirin and statin therapy with 28-day, 90-day, and 1-year mortality in SIMI patients using multivariable Cox regression and Kaplan-Meier analysis. Robustness was assessed via floating absolute risk analysis. External validation was performed in an independent ICU cohort. Results: Among 1,884 SIMI patients, 119 received combination therapy. Compared to those without aspirin or statin, combination therapy was associated with significantly lower mortality at 28 days (11.8% vs. 41.9%; HR = 0.22), 90 days (15.1% vs. 44.8%; HR = 0.23), and 1 year (29.4% vs. 50.9%; HR = 0.38) (all P < 0.001). The combination consistently showed the greatest risk reduction. Subgroup analysis confirmed consistent benefits. External validation (n = 4,002) confirmed a lower 28-day mortality risk with combination therapy (HR = 0.48; P < 0.001). Conclusion: Combined aspirin and statin therapy is associated with reduced mortality and improved outcomes in SIMI patients.Keywords
Funding Information
- National Natural Science Foundation of China (82170352)
- National Natural Science Foundation of China (82472193)
This publication has 30 references indexed in Scilit:
- Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: An analysis of the MIMIC-IV databaseJournal of Clinical Anesthesia, 2024
- MIMIC-IV, a freely accessible electronic health record datasetScientific Data, 2023
- Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signalingPharmacological Research, 2022
- Major Global Coronary Artery Calcium GuidelinesJACC: Cardiovascular Imaging, 2022
- Pathophysiology of sepsis-induced cardiomyopathyNature Reviews Cardiology, 2021
- Cyclooxygenases and the cardiovascular systemPharmacology & Therapeutics, 2021
- Platelet activation and antiplatelet therapy in sepsis: A narrative reviewThrombosis Research, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Lipoxins and aspirin-triggered lipoxins in resolution of inflammationEuropean Journal of Pharmacology, 2015
- Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia–reperfusion-induced endothelial cell apoptosisApoptosis, 2007